Terms: = Sarcomas AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1
226 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion.
Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
[TBL] [Abstract] [Full Text] [Related]
3. FTIR Microspectroscopy as a new probe to study human uterine lesions: Characterization of tumor cell lines from uterine smooth muscle cells and evaluation of epa and DHA in vitro treatments.
Belloni A; Notarstefano V; Greco S; Pellegrino P; Giorgini E; Ciarmela P
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166873. PubMed ID: 37666437
[TBL] [Abstract] [Full Text] [Related]
4. A prospective cohort study of timp1 as prognostic biomarker in gastric and colon cancer.
Macedo FC; Cunha N; Pereira TC; Soares RF; Monteiro AR; Bonito N; Valido F; Sousa G
Chin Clin Oncol; 2022 Dec; 11(6):43. PubMed ID: 36509552
[TBL] [Abstract] [Full Text] [Related]
5. ESR1 mediated circ_0004018 suppresses angiogenesis in hepatocellular carcinoma via recruiting FUS and stabilizing timp2 expression.
Wu Y; Zhang M; Bi X; Hao L; Liu R; Zhang H
Exp Cell Res; 2021 Nov; 408(2):112804. PubMed ID: 34487732
[TBL] [Abstract] [Full Text] [Related]
6. The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish models.
De Vita A; Recine F; Miserocchi G; Pieri F; Spadazzi C; Cocchi C; Vanni S; Liverani C; Farnedi A; Fabbri F; Fausti V; Casadei R; Brandolini F; Ercolani G; Cavaliere D; Bongiovanni A; Riva N; Gurrieri L; Di Menna G; Calpona S; Debonis SA; Mercatali L; Ibrahim T
J Exp Clin Cancer Res; 2021 May; 40(1):165. PubMed ID: 33975637
[TBL] [Abstract] [Full Text] [Related]
7. Eicosapentaenoic Acid Inhibits
Chiu CF; Hsu MI; Yeh HY; Park JM; Shen YS; Tung TH; Huang JJ; Wu HT; Huang SY
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801246
[TBL] [Abstract] [Full Text] [Related]
8. Inhibitory effects on chondrosarcoma cell metastasis by Senna alata extract.
Kittiwattanokhun A; Samosorn S; Innajak S; Watanapokasin R
Biomed Pharmacother; 2021 May; 137():111337. PubMed ID: 33582453
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear factor-κB plays an important role in Tamarixetin-mediated inhibition of matrix metalloproteinase-9 expression.
Shaji SK; G D; Sunilkumar D; Pandurangan N; Kumar GB; Nair BG
Eur J Pharmacol; 2021 Feb; 893():173808. PubMed ID: 33345858
[TBL] [Abstract] [Full Text] [Related]
10. The Pyrazolo[3,4-
Neuber C; Tröster A; Löser R; Belter B; Schwalbe H; Pietzsch J
Molecules; 2020 Nov; 25(21):. PubMed ID: 33153234
[TBL] [Abstract] [Full Text] [Related]
11. Effect of Lapachol on the Inhibition of Matrix Metalloproteinase Related to the Invasion of Human Fibrosarcoma Cells.
Kim J; Kim MM
Curr Mol Pharmacol; 2021 Oct; 14(4):620-626. PubMed ID: 33019942
[TBL] [Abstract] [Full Text] [Related]
12. Identification and Functional Analysis of epoR
Li Y; Li M; Wei R; Wu J
J Immunol Res; 2020; 2020():9374240. PubMed ID: 32908942
[TBL] [Abstract] [Full Text] [Related]
13. Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: A case report and review of the literature.
Fanelli M; Caputo F; Cerma K; Gelsomino F; Bari A; Dominici M; Pozzi S
J Oncol Pharm Pract; 2021 Apr; 27(3):766-770. PubMed ID: 32838682
[TBL] [Abstract] [Full Text] [Related]
14. RECK and timp-2 mediate inhibition of MMP-2 and MMP-9 by
Drishya G; Nambiar J; Shaji SK; Vanuopadath M; Achuthan A; Kumar A; Alias A; Sherif A; Joseph C; Divya P; Kumar DS; Bose C; Nair SV; Sudarslal S; Kumar GB; Lakshmi S; Nair BG
J Biosci; 2020; 45():. PubMed ID: 32661216
[TBL] [Abstract] [Full Text] [Related]
15. In vivo imaging of cell proliferation in meningioma using 3'-deoxy-3'-[
Bashir A; Binderup T; Vestergaard MB; Broholm H; Marner L; Ziebell M; Fugleholm K; Kjær A; Law I
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1496-1509. PubMed ID: 32047966
[TBL] [Abstract] [Full Text] [Related]
16. Advances in patent applications related to cancer vaccine using CpG-ODN and OX40 association.
Quintella CM; Quintella HM; Rohweder M; Quintella GM
Expert Opin Ther Pat; 2020 Apr; 30(4):287-301. PubMed ID: 32008403
[No Abstract] [Full Text] [Related]
17. Effects of simvastatin on matrix metalloproteinase regulation in IL-1β-induced SW1353 cells.
Cecen B; Keles D; Oktay G; Kozaci LD
Chem Biol Interact; 2019 Sep; 310():108730. PubMed ID: 31260663
[TBL] [Abstract] [Full Text] [Related]
18. The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation.
Shrestha M; Ando T; Chea C; Sakamoto S; Nishisaka T; Ogawa I; Miyauchi M; Takata T
Carcinogenesis; 2019 Oct; 40(10):1288-1297. PubMed ID: 31074490
[TBL] [Abstract] [Full Text] [Related]
19. Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1.
Li S; Pei Y; Wang W; Liu F; Zheng K; Zhang X
Biomed Pharmacother; 2019 Jun; 114():108839. PubMed ID: 30978523
[TBL] [Abstract] [Full Text] [Related]
20. The specific RIP1 inhibitor necrostatin-1 ameliorated degradation of ECM in human SW1353 cells.
Hu X; Zhu Y; Wang J; Tang J; Yu H; Xie Y; Dong Q
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1169-S1175. PubMed ID: 30604633
[TBL] [Abstract] [Full Text] [Related]
[Next]
